Skip to main content

Peroxisomal acyl-CoA oxidase deficiency

Peroxisomal acyl-CoA oxidase deficiency



Overview

Peroxisomal acyl-CoA oxidase deficiency is a rare inherited disorder that causes severe neurodegeneration, weak muscle tone, and seizures starting in infancy. Caused by mutations in the \(ACOX1\) gene, it leads to a toxic accumulation of very long-chain fatty acids and is typically fatal in early childhood.

Symptoms

Peroxisomal acyl-CoA oxidase deficiency is a rare, inherited neurodegenerative disorder. It primarily presents in infancy with weak muscle tone (hypotonia), recurrent seizures, and distinctive facial features (such as widely spaced eyes and a low nasal bridge). While some developmental milestones are initially achieved, a devastating loss of skills typically follows.

A structured breakdown of the symptoms includes:

Early / Neonatal Symptoms (From Birth)

Neurological: Severe neonatal hypotonia (weak muscle tone) and neonatal seizures.

Facial Dysmorphism: Distinct features like a depressed/low nasal bridge, widely spaced eyes (hypertelorism), low-set ears, and frontal bossing.

Physical Anomalies: Potential for an enlarged liver (hepatomegaly) or extra fingers and toes (polydactyly).Neurological Regression & Progressive Symptoms

Skill Loss: Children typically begin speaking and walking, but experience a sharp regression and loss of psychomotor skills (usually between the ages of 1 and 3).

Muscle & Reflex Changes: Weak muscle tone is replaced by high muscle tone (hypertonia), exaggerated reflexes (hyperreflexia), and spasticity.

Neurodegeneration: Progressive intellectual disability, worsening epilepsy, and central nervous system demyelination (destruction of the nerve-insulating myelin sheath).

Sensory and Vision Symptoms

Hearing Loss: Bilateral sensorineural hearing impairment leading to progressive deafness.

Vision Loss: Diminishing response to stimuli and degradation of the eyes, manifesting as optic atrophy, involuntary eye movements (nystagmus), and retinal dystrophy.

Causes

The Enzyme: \(ACOX1\) is responsible for producing the enzyme needed to break down certain dietary fats.

The Mechanism: When \(ACOX1\) is mutated, the body cannot process VLCFAs. Their buildup causes severe inflammation and destroys white matter in the brain and spinal cord.

Inheritance: It is inherited in an autosomal recessive pattern, meaning a child must inherit one mutated copy of the gene from both parents to develop the condition.

Diagnosis

Peroxisomal acyl-CoA oxidase deficiency is diagnosed through a combination of blood tests, enzymatic analysis, and genetic testing. The process typically involves:

Biochemical Screening: Measuring plasma levels of Very Long-Chain Fatty Acids (VLCFAs). Elevated VLCFAs (specifically C24 and C26) and normal plasmalogen levels strongly indicate a single peroxisomal enzyme defect rather than a biogenesis disorder.

Enzymatic Assay: Testing cultured skin fibroblasts to reveal markedly reduced or absent acyl-CoA oxidase enzyme activity.

Genetic Testing: Confirming the diagnosis by identifying pathogenic mutations in the ACOX1 gene through targeted gene panels or clinical exome sequencing.

Imaging: An MRI of the brain is often performed to identify abnormal white matter signals (leukodystrophy).

Treatment

Because ACOX1 deficiency affects the nervous system and leads to neurological decline, medical intervention focuses on relieving individual symptoms:

Seizures: Managed using standard anti-seizure medications.

Muscle Tone: Pharmacologic agents may be used to address dystonia (involuntary muscle contractions) or improve movement.

Physical Therapy: Utilized to maintain muscle function and mobility

Current medical science continues to investigate personalized treatments and clinical interventions:

Hematopoietic Stem Cell Transplantation (HSCT): HSCT has been evaluated in some affected siblings; however, outcomes and long-term efficacy are still being studied.

Drug Repurposing: Studies have shown that certain small molecules, such as the drug niclosamide, can significantly reduce Very Long-Chain Fatty Acid (VLCFA) levels in cellular assays and are being investigated for individualized patient management

Type of Doctor Department : A Metabolic Geneticist or a Pediatric Neurologist

Comments

Post a Comment

Popular posts from this blog

Charge Syndrome

Overview CHARGE syndrome is a recognizable genetic syndrome with known pattern of features. It is an extremely complex syndrome, involving extensive medical and physical difficulties that differ from child to child. CHARGE syndrome is correlated with genetic mutation to CHD7 and the prevalence of CHARGE syndrome is 1:10,000-1:15,000 live births. Babies with CHARGE syndrome are often born with life-threatening birth defects. They spend many months in the hospital and undergo many surgeries and other treatments. Swallowing and breathing problems make life difficult even when they come home. Most have hearing two little girls sitting on a carpet, one girl has a trach and is biting her finger.loss, vision loss, and balance problems that delay their development and communication. Despite these seemingly insurmountable obstacles, children with CHARGE syndrome often far surpass their medical, physical, educational, and social expectations. One of the hidden features of CHARGE syndrome is the ...
7 comments
Read more

Dehydration Due to Diarrheal Diseases

Overview Dehydration occurs when you use or lose more fluid than you take in, and your body doesn't have enough water and other fluids to carry out its normal functions. If you don't replace lost fluids, you will get dehydrated. Anyone may become dehydrated, but the condition is especially dangerous for young children and older adults. The most common cause of dehydration in young children is severe diarrhea and vomiting. Older adults naturally have a lower volume of water in their bodies, and may have conditions or take medications that increase the risk of dehydration. This means that even minor illnesses, such as infections affecting the lungs or bladder, can result in dehydration in older adults. Dehydration also can occur in any age group if you don't drink enough water during hot weather — especially if you are exercising vigorously. You can usually reverse mild to moderate dehydration by drinking more fluids, but severe dehydration needs immediate medical treatment. ...
Post a Comment
Read more

Vogt-Koyanagi-Harada (VKH) Disease

  Vogt-Koyanagi-Harada (VKH) Disease Disease Overview Vogt-Koyanagi-Harada disease is a rare disorder of unknown origin that affects many body systems, including as the eyes, ears, skin, and the covering of the brain and spinal cord (the meninges). The most noticeable symptom is a rapid loss of vision. There may also be neurological signs such as severe headache, vertigo, nausea, and drowsiness. Loss of hearing, and loss of hair (alopecia) and skin color may occur along, with whitening (loss of pigmentation) of the hair and eyelashes (poliosis). Signs & Symptoms Vogt-Koyanagi-Harada disease is initially characterized by headaches, very deep pain in the eyes, dizziness (vertigo), and nausea. These symptoms are usually followed in a few weeks by eye inflammation (uveitis) and blurring of vision. This may occur in both eyes at the same time or in one eye first and, a few days later, in the other. The retina may detach and hearing loss may become apparent. The chronic stage follows...
Post a Comment
Read more